Devyser Diagnostics AB (publ) (DVYSR.ST)

SEK 117.0

(0.0%)

Net Income Summary of Devyser Diagnostics AB (publ)

  • Devyser Diagnostics AB (publ)'s latest annual net income in 2023 was -53.6 Million SEK , down -16.64% from previous year.
  • Devyser Diagnostics AB (publ)'s latest quarterly net income in 2024 Q1 was -12.2 Million SEK , up 6.87% from previous quarter.
  • Devyser Diagnostics AB (publ) reported an annual net income of -45.95 Million SEK in 2022, down -121.71% from previous year.
  • Devyser Diagnostics AB (publ) reported an annual net income of -20.72 Million SEK in 2021, down -89.96% from previous year.
  • Devyser Diagnostics AB (publ) reported a quarterly net income of -23.2 Million SEK for 2024 Q3, down -1.31% from previous quarter.
  • Devyser Diagnostics AB (publ) reported a quarterly net income of -12.2 Million SEK for 2024 Q1, up 6.87% from previous quarter.

Annual Net Income Chart of Devyser Diagnostics AB (publ) (2023 - 2018)

Historical Annual Net Income of Devyser Diagnostics AB (publ) (2023 - 2018)

Year Net Income Net Income Growth
2023 -53.6 Million SEK -16.64%
2022 -45.95 Million SEK -121.71%
2021 -20.72 Million SEK -89.96%
2020 -10.91 Million SEK -255.67%
2019 7 Million SEK 1250.48%
2018 519 Thousand SEK 0.0%

Peer Net Income Comparison of Devyser Diagnostics AB (publ)

Name Net Income Net Income Difference
AroCell AB (publ) -59.29 Million SEK 9.608%
Immunovia AB (publ) -309.43 Million SEK 82.678%
Prostatype Genomics AB (publ) -41.43 Million SEK -29.359%
SenzaGen AB -22.09 Million SEK -142.567%
Spermosens AB -12.2 Million SEK -339.272%